FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Debra Breneman

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Anatomy

Skin

Co-author Network

Publications

TOP 3
James T Edinger; Cynthia R Lorenzo; Debra L Breneman; Steven H Swerdlow
Primary cutaneous marginal zone lymphoma with subclinical cutaneous involvement and biclonality.
Farah R Abdulla; Christopher Breneman; Brian Adams; Debra L Breneman
Standards for genital protection in phototherapy units.
Madeleine Duvic; Elise A Olsen; Debra L Breneman; Theresa R Pacheco; Sareeta Parker; Eric Vonderheid; Rachel Abuav; Justin L Ricker; Syed Rizvi; Cong Chen; Kathleen Boileau; Alexandra Gunchenko; Cesar Sanz-Rodriguez; Larisa J Geskin
Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Debra Breneman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: James T Edinger; Cynthia R Lorenzo; Debra L Breneman; Steven H Swerdlow
Primary cutaneous marginal zone lymphoma with subclinical cutaneous involvement and biclonality.
Journal of cutaneous pathology 2011;38(9):724-30.
2010: Farah R Abdulla; Christopher Breneman; Brian Adams; Debra L Breneman
Standards for genital protection in phototherapy units.
Journal of the American Academy of Dermatology 2010;62(2):223-6.
2009: Madeleine Duvic; Elise A Olsen; Debra L Breneman; Theresa R Pacheco; Sareeta Parker; Eric Vonderheid; Rachel Abuav; Justin L Ricker; Syed Rizvi; Cong Chen; Kathleen Boileau; Alexandra Gunchenko; Cesar Sanz-Rodriguez; Larisa J Geskin
Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma.
Clinical lymphoma & myeloma 2009;9(6):412-6.
2008: Debra L Breneman; Timothy J Storer; John C. Breneman; Diya F Mutasim
Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides.
Therapeutics and clinical risk management 2008;4(5):1135-41.
2008: Debra L Breneman; Alan B Fleischer; William Abramovits; Joshua Zeichner; Michael H Gold; Robert S Kirsner; Toni F Shull; Andrew W Crowe; Eileen Jaracz; Jon M Hanifin
Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.
Journal of the American Academy of Dermatology 2008;58(6):990-9.
2007: Peter Heald; Antonio Subtil; Debra L Breneman; Lynn D Wilson
Persistent agmination of lymphomatoid papulosis: an equivalent of limited plaque mycosis fungoides type of cutaneous T-cell lymphoma.
Journal of the American Academy of Dermatology 2007;57(6):1005-11.
2007: Debra L Breneman; Pranav Sheth; Vivian Berger; Vahid Naini; Victor J. Stevens
Phase II clinical trial of bexarotene gel 1% in psoriasis.
Journal of drugs in dermatology : JDD 2007;6(5):501-6.
2004: Jon M Hanifin; Victor J. Stevens; P Sheth; Debra L Breneman
Novel treatment of chronic severe hand dermatitis with bexarotene gel.
The British journal of dermatology 2004;150(3):545-53.
2003: Debra L Breneman; Uma S Raju; John C. Breneman; Paul E Steele; David W McFadden; Hernani Cualing; Michael S Nussbaum; Steven H Swerdlow
Lymph node grading for staging of mycosis fungoides may benefit from examination of multiple excised lymph nodes.
Journal of the American Academy of Dermatology 2003;48(5):702-6.
2002: Brittain F Kulow; Hernani Cualing; Paul E Steele; Judi VanHorn; John C. Breneman; Diya F Mutasim; Debra L Breneman
Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma.
Journal of cutaneous medicine and surgery 2002;6(6):519-28.
2002: Debra L Breneman; Madeleine Duvic; Timothy Kuzel; Richard C Yocum; Joseph Truglia; Victor J. Stevens
Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma.
Archives of dermatology 2002;138(3):325-32.
2001: Madeleine Duvic; K Hymes; Peter Heald; Debra L Breneman; Ann Martin; Patricia L Myskowski; Constance Crowley; Richard C Yocum
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(9):2456-71.
2001: LA Drake; M Prendergast; Rochelle M Maher; Debra L Breneman; N Korman; Y Satoi; K M Beusterien; I Lawrence
The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis.
Journal of the American Academy of Dermatology 2001;44(1 Suppl):S65-72.
2001: Jon M Hanifin; Mark R Ling; R Langley; Debra L Breneman; Elyse S Rafal
Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy.
Journal of the American Academy of Dermatology 2001;44(1 Suppl):S28-38.
2000: Debra L Breneman; Jon M Hanifin; C A Berge; B H Keswick; P B Neumann
The effect of antibacterial soap with 1.5% triclocarban on Staphylococcus aureus in patients with atopic dermatitis.
Cutis; cutaneous medicine for the practitioner 2000;66(4):296-300.
2000: C M Adamick; Debra L Breneman
Diffuse and progressive papules and nodules.
Archives of dermatology 2000;136(6):793, 796.
1998: Mark Lebwohl; Debra L Breneman; Bernard S Goffe; J R Grossman; Mark R Ling; J Milbauer; S H Pincus; R G Sibbald; Leonard J Swinyer; Gerald D Weinstein; Deborah A Lew-Kaya; JC Lue; John R Gibson; John Sefton
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
Journal of the American Academy of Dermatology 1998;39(4 Pt 1):590-6.
1998: T Ploysangam; Debra L Breneman; Diya F Mutasim
Cutaneous pseudolymphomas.
Journal of the American Academy of Dermatology 1998;38(6 Pt 1):877-95; quiz 896-7.
1998: Ronald Savin; LA Drake; DE Babel; Daniel M Stewart; Phoebe Rich; Mark R Ling; Debra L Breneman; Richard Scher; Ann Martin; David M Pariser; Robert J Pariser; Charles Ellis; Sewon Kang; D Friedman; H Irving Katz; CJ McDonald; JJ Muglia; Guy Webster; Boni E Elewski; James J Leyden; AD Bucko; Eduardo Tschen; Jon M Hanifin; Manuel Morman; J Hilbert
Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail.
Journal of the American Academy of Dermatology 1998;38(6 Pt 2):S110-6.
1998: Phoebe Rich; Richard Scher; Debra L Breneman; Ronald Savin; D S Feingold; N Konnikov; Jerome L Shupack; S Pinnell; N Levine; Nicholas J Lowe; Raza Aly; Richard B Odom; DL Greer; Manuel Morman; AD Bucko; Eduardo Tschen; Boni E Elewski; EB Smith; J Hilbert
Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.
Journal of the American Academy of Dermatology 1998;38(6 Pt 2):S103-9.
1998: LA Drake; DE Babel; Daniel M Stewart; Phoebe Rich; Mark R Ling; Debra L Breneman; Richard Scher; Ann Martin; David M Pariser; Robert J Pariser; Charles Ellis; Sewon Kang; H Irving Katz; CJ McDonald; JJ Muglia; Ronald Savin; Guy Webster; Boni E Elewski; James J Leyden; AD Bucko; Eduardo Tschen; Jon M Hanifin; Manuel Morman; Jerome L Shupack; DL Greer
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.
Journal of the American Academy of Dermatology 1998;38(6 Pt 2):S87-94.
1998: Richard Scher; Debra L Breneman; Phoebe Rich; Ronald Savin; D S Feingold; N Konnikov; Jerome L Shupack; S Pinnell; N Levine; Nicholas J Lowe; Raza Aly; Richard B Odom; DL Greer; Manuel Morman; AD Bucko; Eduardo Tschen; Boni E Elewski; EB Smith
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.
Journal of the American Academy of Dermatology 1998;38(6 Pt 2):S77-86.
1998: Debra L Breneman; D Stewart; O Hevia; P D Hino; L A Drake
A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea.
Cutis; cutaneous medicine for the practitioner 1998;61(1):44-7.
1996: David M Pariser; Robert J Pariser; Debra L Breneman; Mark Lebwohl; R Kalb; J Moore; H Moss; C Parker; VC Fiedler
Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.
Archives of dermatology 1996;132(12):1527.
1996: Mark Lebwohl; S B Siskin; W Epinette; Debra L Breneman; T Funicella; R Kalb; J Moore
A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.
Journal of the American Academy of Dermatology 1996;35(2 Pt 1):268-9.
1993: Bradley Doebbeling; Debra L Breneman; H C Neu; R Aly; B G Yangco; H P Holley; R J Marsh; Michael A Pfaller; J E McGowan; B E Scully
Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(3):466-74.
1992: E B Smith; Debra L Breneman; R F Griffith; Adelaide A Hebert; J G Hickman; J M Maloney; Larry E Millikan; Virginia I Sulica; S H Dromgoole; John Sefton
Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis.
Journal of the American Academy of Dermatology 1992;26(1):125-7.